226 related articles for article (PubMed ID: 16302000)
1. G-Quadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by loss of the 3' telomeric overhang in cancer cells.
Tahara H; Shin-Ya K; Seimiya H; Yamada H; Tsuruo T; Ide T
Oncogene; 2006 Mar; 25(13):1955-66. PubMed ID: 16302000
[TBL] [Abstract][Full Text] [Related]
2. The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells.
Gomez D; O'Donohue MF; Wenner T; Douarre C; Macadré J; Koebel P; Giraud-Panis MJ; Kaplan H; Kolkes A; Shin-ya K; Riou JF
Cancer Res; 2006 Jul; 66(14):6908-12. PubMed ID: 16849533
[TBL] [Abstract][Full Text] [Related]
3. The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures.
Kim MY; Gleason-Guzman M; Izbicka E; Nishioka D; Hurley LH
Cancer Res; 2003 Jun; 63(12):3247-56. PubMed ID: 12810655
[TBL] [Abstract][Full Text] [Related]
4. A G-quadruplex-interactive agent, telomestatin (SOT-095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemia.
Sumi M; Tauchi T; Sashida G; Nakajima A; Gotoh A; Shin-Ya K; Ohyashiki JH; Ohyashiki K
Int J Oncol; 2004 Jun; 24(6):1481-7. PubMed ID: 15138591
[TBL] [Abstract][Full Text] [Related]
5. Critically short telomeres in acute myeloid leukemia with loss or gain of parts of chromosomes.
Swiggers SJ; Kuijpers MA; de Cort MJ; Beverloo HB; Zijlmans JM
Genes Chromosomes Cancer; 2006 Mar; 45(3):247-56. PubMed ID: 16281260
[TBL] [Abstract][Full Text] [Related]
6. Telomere length homeostasis requires that telomerase levels are limiting.
Cristofari G; Lingner J
EMBO J; 2006 Feb; 25(3):565-74. PubMed ID: 16424902
[TBL] [Abstract][Full Text] [Related]
7. Establishment of functional telomerase immortalized human hepatocytes and a hepatic stellate cell line for telomere-targeting anticancer drug development.
Waki K; Anno K; Ono T; Ide T; Chayama K; Tahara H
Cancer Sci; 2010 Jul; 101(7):1678-85. PubMed ID: 20456367
[TBL] [Abstract][Full Text] [Related]
8. Telomerase inhibition, telomere shortening, cell growth suppression and induction of apoptosis by telomestatin in childhood neuroblastoma cells.
Binz N; Shalaby T; Rivera P; Shin-ya K; Grotzer MA
Eur J Cancer; 2005 Dec; 41(18):2873-81. PubMed ID: 16253503
[TBL] [Abstract][Full Text] [Related]
9. TRF2 overexpression diminishes repair of telomeric single-strand breaks and accelerates telomere shortening in human fibroblasts.
Richter T; Saretzki G; Nelson G; Melcher M; Olijslagers S; von Zglinicki T
Mech Ageing Dev; 2007 Apr; 128(4):340-5. PubMed ID: 17395247
[TBL] [Abstract][Full Text] [Related]
10. A mathematical model of cellular apoptosis and senescence through the dynamics of telomere loss.
Arkus N
J Theor Biol; 2005 Jul; 235(1):13-32. PubMed ID: 15833310
[TBL] [Abstract][Full Text] [Related]
11. Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia.
Tauchi T; Shin-ya K; Sashida G; Sumi M; Okabe S; Ohyashiki JH; Ohyashiki K
Oncogene; 2006 Sep; 25(42):5719-25. PubMed ID: 16652154
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
[TBL] [Abstract][Full Text] [Related]
13. A new steroid derivative stabilizes g-quadruplexes and induces telomere uncapping in human tumor cells.
Brassart B; Gomez D; De Cian A; Paterski R; Montagnac A; Qui KH; Temime-Smaali N; Trentesaux C; Mergny JL; Gueritte F; Riou JF
Mol Pharmacol; 2007 Sep; 72(3):631-40. PubMed ID: 17586599
[TBL] [Abstract][Full Text] [Related]
14. [Telomerase inhibitor, telomestatin, a specific mechanism to interact with telomere structure].
Shin-ya K
Nihon Rinsho; 2004 Jul; 62(7):1277-82. PubMed ID: 15283144
[TBL] [Abstract][Full Text] [Related]
15. Energetics of the human Tel-22 quadruplex-telomestatin interaction: a molecular dynamics study.
Agrawal S; Ojha RP; Maiti S
J Phys Chem B; 2008 Jun; 112(22):6828-36. PubMed ID: 18461983
[TBL] [Abstract][Full Text] [Related]
16. Binding of G-quadruplex-interactive agents to distinct G-quadruplexes induces different biological effects in MiaPaCa cells.
Liu W; Sun D; Hurley LH
Nucleosides Nucleotides Nucleic Acids; 2005; 24(10-12):1801-15. PubMed ID: 16438049
[TBL] [Abstract][Full Text] [Related]
17. Accumulation and altered localization of telomere-associated protein TRF2 in immortally transformed and tumor-derived human breast cells.
Nijjar T; Bassett E; Garbe J; Takenaka Y; Stampfer MR; Gilley D; Yaswen P
Oncogene; 2005 May; 24(20):3369-76. PubMed ID: 15735711
[TBL] [Abstract][Full Text] [Related]
18. Studying telomere replication by Q-CO-FISH: the effect of telomestatin, a potent G-quadruplex ligand.
Arnoult N; Shin-Ya K; Londoño-Vallejo JA
Cytogenet Genome Res; 2008; 122(3-4):229-36. PubMed ID: 19188691
[TBL] [Abstract][Full Text] [Related]
19. DNA structure-dependent recruitment of telomeric proteins to single-stranded/double-stranded DNA junctions.
Yanez GH; Khan SJ; Locovei AM; Pedroso IM; Fletcher TM
Biochem Biophys Res Commun; 2005 Mar; 328(1):49-56. PubMed ID: 15670749
[TBL] [Abstract][Full Text] [Related]
20. A RAP1/TRF2 complex inhibits nonhomologous end-joining at human telomeric DNA ends.
Bae NS; Baumann P
Mol Cell; 2007 May; 26(3):323-34. PubMed ID: 17499040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
